V. Craig Jordan

Professor V. Craig Jordan, CMG, OBE Virgil Craig Jordan, , is a scientist with American and British citizenship specializing in drugs for breast cancer treatment and prevention. Currently, he is Professor of Breast Medical Oncology, and Professor of Molecular and Cellular Oncology at the University of Texas MD Anderson Cancer Center, Houston, Texas. Previously, he was Scientific Director and Vice Chairman of Oncology at the Lombardi Comprehensive Cancer Center of Georgetown University. Jordan was the first to discover the breast cancer prevention properties of tamoxifen and the scientific principles for adjuvant therapy with antihormones. More recently his work has branched out into the prevention of multiple diseases in women with the discovery of the drug group, selective estrogen receptor modulator (SERMs). Currently, he plans to develop a new Hormone Replacement Therapy (HRT) for post-menopausal women that prevents breast cancer and does not increase the risk of breast cancer.

A highly regarded researcher, his paper ''The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women - Results from the more Randomized Trial'' was one of the top 20 most cited papers in breast cancer research during 2003 and 2004. Provided by Wikipedia

by Jordan, V. Craig
Published 2002
Humana Press

by Jordan, V. Craig
Published 2011
Henry Stewart Talks

by Jordan, V. Craig
Published 2011
Henry Stewart Talks

by Maximov, Philipp Y., McDaniel, Russell E., Jordan, V. Craig
Published 2013
Springer Basel

by Senn, Hans-Jörg
Published 1999
Springer Berlin Heidelberg
Other Authors: '; ...Jordan, V. Craig...